Cingulate Director Receives 15,000 Stock Options at $4.14 Strike Price

Director Peter J. Werth of Cingulate received a stock option grant for 15,000 shares of common stock on June 20, 2025.

Rhea-AI Filing Summary

Director Peter J. Werth of Cingulate received a stock option grant for 15,000 shares of common stock on June 20, 2025. The options were granted with an exercise price of $4.14 per share and will expire on June 20, 2035.

Key terms of the option grant:

• Vesting occurs at the earlier of: one-year anniversary of grant date or the 2026 annual stockholder meeting
• Transaction reported as a Form 4 filing indicating changes in beneficial ownership
• Options were acquired at no cost ($0) as part of director compensation

The filing was signed by Shane J. Schaffer as attorney-in-fact on June 23, 2025. This equity grant appears to be part of standard director compensation arrangements and represents a new beneficial ownership position for the reporting person.

Insider Trade Summary

Grant/Award: 15,000 shares

Grant/Award 1 txn

Insider Werth Peter J.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (right to Buy)	15,000	$0.00	$0.00

Holdings After Transaction: Stock Option (right to Buy) — 15,000 contracts (Direct)

Footnotes (1)

1. F1. The option vests on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Cingulate Inc. 2026 annual meeting of stockholders.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock options did Peter J. Werth receive from CINGW on June 20, 2025?

Peter J. Werth received 15,000 stock options with an exercise price of $4.14 per share. These options were granted on June 20, 2025, and will expire on June 20, 2035.

When do Peter Werth's CINGW stock options vest?

The stock options vest on the earlier of two conditions: (1) the one-year anniversary of the grant date (June 20, 2026) or (2) the date of Cingulate Inc.'s 2026 annual meeting of stockholders.

What is Peter J. Werth's role at CINGW?

According to the Form 4 filing, Peter J. Werth serves as a Director of Cingulate Inc. (CING/CINGW), as indicated by the 'X' marked in the Director box under the relationship section.

What was the total value of stock options granted to Peter Werth in this CINGW insider transaction?

The Form 4 shows that Peter Werth received 15,000 stock options at an exercise price of $4.14 per share. The filing indicates the price of the derivative security was $0, meaning these were granted as compensation rather than purchased.

Where is CINGW's Director Peter Werth located?

According to the Form 4 filing, Peter J. Werth's address is listed as 1901 W. 47th Place, Kansas City, KS 66205.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/23/2025 - 08:02 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Werth Peter J.

(Last) (First) (Middle)

1901 W. 47TH PLACE

(Street)

KANSAS CITY KS 66205

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Cingulate Inc. [ CING ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/20/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (right to Buy)	$4.14	06/20/2025		A		15,000		(1)	06/20/2035	Common Stock	15,000	$0	15,000	D

Explanation of Responses:

1. The option vests on the earlier of (i) the one-year anniversary of the date of grant and (ii) the date of the Cingulate Inc. 2026 annual meeting of stockholders.

	/s/ Shane J. Schaffer, Attorney-in-Fact	06/23/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.